Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine.

Authors

  • G. M. Daragan
  • T. Yu. Krushinska
  • D. O. Stepanskiy
  • I. V. Demchyshyna
  • I. P. Kolesnikova

DOI:

https://doi.org/10.26641/2307-0404.2018.1(part1).127206

Keywords:

vaccination, measles, rubella, elimination

Abstract

The analysis of measles and rubella morbidity, the state of their vaccination in Ukraine was carried out. Despite decades of preventive vaccination, there is a 5-6 years’ cyclicity of measles epidemic process at present time. Measles morbidity increased 46.8 times in 2017 in comparison with 2016. Elevated rates of rubella epidemic morbidity were registered in 2004 and 2011. There was decrease of routine measles and rubella immunization coverage in the period from 2009 to 2016. Critically low rates were noted in 2016 – 45.5% (vaccination) and 30.2% (revaccination). In spite of progress in the measles and rubella vaccination in 2017 (93.3% – vaccination and 90.7% – revaccination), Ukraine has not achieved the immunization coverage (≥95.0%) necessary to interrupt these pathogens circulation. The national laboratory and a network of regional ones, in-system of the Global Measles and Rubella Laboratory Network, were established in Ukraine to ensure high-quality performance of epidemiological surveillance. Genotyping of the clinical samples from Ukrainian measles and rubella patients is carried out in the WHO Regional Reference Laboratory (Luxembourg). Different genetic lines of the measles virus with prevalence of D8 genotype were indicated to circulate in Ukraine. The genotype B3 was also identified and the genotype D9 was isolated for the first time. In the furtherance of the goal of rubella and measles elimination in Ukraine, standard international approaches to clinical, laboratory and epide­miological diagnosis of cases, investigation of viruses transmission chains and detection of endemicity cases are in the course of implementation. Quality of the executing activities is assessed according to relevant standard indicators.

Author Biographies

G. M. Daragan

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

T. Yu. Krushinska

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

D. O. Stepanskiy

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

I. V. Demchyshyna

SI «Public Health Center of the Ministry of Health of Ukraine» 
S. Bandery ave., 19, Kyiv, 04655, Ukraine

I. P. Kolesnikova

Bogomolets National medical university
T. Shevchenko boulevard, 13, Kyiv, 01601, Ukraine

References

Timchenko VN, Kaplina TA, Bulina OV, Leoni­cheva OA, Khakizimana ZhK, Timofeeva EV. [Actual problems of measles]. Pediatr. 2017;8(3):120-9. Russian. doi: 10.17816/PED83120-129

Chudna LM, Zadorozhna VI, Marychev IL, De­mchishina IV. [Vaccine and its impact on the incidence of infections managed by means of specific im­munization]. Profilaktychna medicina. 2013;1-2(20):3-10. Ukrainian.

Zherebtsova NY, Evdokimov VI, Shchibrik EV, Chebotareva TY, Mezenceva AL. [Characteristics of epi­demiology of measles in the modern stage in Belgorod region]. Nauchnye vedomosti BelGU. Seriya Meditsina. Farmatsiya. 2014;4(175):253-7. Russian.

MarichevIL, Brizhata SI, Protsap EI, Nekrasova LS, Svita VN,Vasheka LN.[State of measles vaccination inukraineand its impact on the epidemic process]. Pro­filaktychna medicina. 2012;3-4(19):3-7. Ukrainian.

Krasyuk LS, Bіlomerya TA, AlayevaOM, Kis­lyak ІІ, Alekseeva ІV, Myshko OV. [Trends of rubella’s epidemic process inukraine]. Profilaktychna medicina. 2012;2(18):57-59. Ukrainian.

MuldersMN, Serhan F, Goodson JL, Icenogle J, Johnson BW,RotaPA. Expansion of Surveillance for Vac­cine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Ru­bella Laboratory Network Platforms. The Journal of In­fectious Diseases. 2017;216(S1):324-330. doi: 10.1093/infdis/jix077

Furuse Y, Oshitani H. Global Transmission Dy­namics of Measles in the Measles Elimination Era. Viruses. 2017;9(4):82. doi: 10.3390/v9040082

Orenstein WA, Cairns L, Hinman A, Nkowane B, Olivé JM, Reingold AL. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: back­ground and summary. Vaccine. 2018;36(l):A35-A42. doi: 10.1016/j.vaccine.2017.10.065

O'Connor P, Jankovic D, Muscat M, Ben-Mamou M, Reef S, Papania M, Singh S, Kaloumenos T, Butler R, Datta S. Measles and rubella elimination in the WHO Re­gion forEurope: progress and challenges. Clin Micro­biol Infect. 2017;23(8):504-10. doi: 10.1016/j.cmi.2017.01.003

Goodson JL, Alexander JP, Linkins RW, Oren­stein WA. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach. Expert Rev Vaccines. 2017;16(12):1203-16. doi: 10.1080/14760584.2017.1393337

Santibanez S, Hübschen JM, Ben Mamou MC, Muscat M, Brown KE, Myers R, Donoso Mantke O, Zeichhardt H, Brockmann D, Shulga SV, Muller CP, O'Connor PM, Mulders MN, Mankertz A. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase. Clin Microbiol Infect. 2017;23(8):516-23. doi: 10.1016/j.cmi.2017.06.030

Coughlin MM, BeckAS, Bankamp B, RotaPA. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses. 2017;9(1):11. doi: 10.3390/v9010011

Plotkin SA, Reef SE. Rubella Vaccine. In: Plotkin SA,OrensteinWA, Offit PA, editors. Vaccines, fifth edi­tion.Philadelphia(PA), Saunders-Elsevier, 2008;735-1.

Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. Progress toward control of rubella and pre­vention of congenital rubella syndrome–worldwide, 2009. J Infect Dis. 2011;204(1);24–7. doi: 10.1093/infdis/jir155

Sniadack DH, Crowcroft NS, Durrheim DN, Rota PA. Roadmap to elimination- standard measles and rubella surveillance. Weekly epidemiological record. 2017;9/10(92):97-105.

How to Cite

1.
Daragan GM, Krushinska TY, Stepanskiy DO, Demchyshyna IV, Kolesnikova IP. Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine. Med. perspekt. [Internet]. 2018Apr.24 [cited 2024Mar.28];23(1(part1):38-43. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/127206

Issue

Section

CLINICAL MEDICINE